NI medtech Cirdan raises £2.3m and creates 25 jobs

Lisburn based Cirdan is a global leader in digital pathology with clients in over 150 laboratories and hospitals across 20 countries and six continents.

Digital pathology player Cirdan has raised £2.3m in new funding to expand its business operations.

The business is also creates up to 25 new jobs ahead of new contract wins.

“This in addition to securing several new contracts will be used to accelerate our operational expansion and deliver on our strong order book for 2023 and beyond”

The investment was led by Kernel Capital through the Bank of Ireland Kernel Capital Growth Fund (NI).  Other investors include Clarendon Fund Managers and high net worth private investors.

Strong order book

“I would like to take this opportunity to thank our investors for their continued support,” said Stephen Dunniece, director, Cirdan.

“This in addition to securing several new contracts will be used to accelerate our operational expansion and deliver on our strong order book for 2023 and beyond.”

The Cirdan platform, which includes specimen imaging solutions, patient and clinician apps as well as the Laboratory information system, collects critical information in a lean and expeditious way, to help transform the time taken for diagnosis and provide new insights into healthcare data.

“Cirdan is a company on a positive growth trajectory with an excellent product, strong team and ‘blue-chip’ clients across 6 continents,” said Denise Sidhu, partner, Kernel Capital.

“The company is ideally placed to capitalise on the accelerated shift from traditional patient care to digital pathology which has the potential to revolutionize timely disease diagnosis leading to better and faster patient care.”

Cirdan’s platform has been shown to improve efficiency and agility, provide greater control and visibility, and seamlessly integrate with digital pathology and AI. 

“Cirdan are a great example of an indigenous company delivering innovative and effective solutions that are making a difference for clinicians and patients both locally and internationally,” said Niall Devlin, head of Business Banking, Bank of Ireland UK.

“We are delighted they have benefited from investment through the Bank of Ireland Kernel Capital Growth Fund, and we look forward to seeing the business further grow and succeed.”

Main image at top: Niall Devlin, Head of Business Banking, Bank of Ireland UK; Denise Sidhu, Partner, Kernel Capital & Stephen Dunniece, Director, Cirdan

John Kennedy
Award-winning ThinkBusiness.ie editor John Kennedy is one of Ireland's most experienced business and technology journalists.

Recommended